Location: Montreal, Quebec, Canada
CIK: 0001274413 · Show all filings
Period: Q4 2013 (← Previous) (Next →)
Filing Date: Feb 12, 2014
Total Value: $2.319B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| BIIB | BIOGEN IDEC INC | 544,575 | $152M | 6.6% | $235.07 | +10.0% | COMMON | 09062X103 |
| GILD | GILEAD SCIENCES INC | 1,941,573 | $146M | 6.3% | $36.21 | +33.6% | COMMON | 375558103 |
| AMGN | AMGEN INC | 1,262,633 | $144M | 6.2% | $74.43 | +9.0% | COMMON | 031162100 |
| — | CELGENE CORP | 706,436 | $119M | 5.1% | $116.98 | — | COMMON | 151020104 |
| VRTX | VERTEX PHARMACEUTICL | 1,232,158 | $91.55M | 3.9% | $73.64 | -5.4% | COMMON | 92532F100 |
| REGN | REGENERON PHARMCTCLS | 276,000 | $75.97M | 3.3% | $251.50 | +13.7% | COMMON | 75886F107 |
| HALO | HALOZYME THERAPEUTIC | 4,701,362 | $70.47M | 3.0% | $7.27 | +76.8% | COMMON | 40637H109 |
| — | THERAVANCE INC | 1,973,188 | $70.34M | 3.0% | $38.49 | — | COMMON | 88338T104 |
| — | SHIRE PLC | 468,759 | $66.23M | 2.9% | $100.74 | — | SP ADR | 82481R106 |
| — | ALEXION PHARM INC | 496,308 | $65.95M | 2.8% | $92.24 | — | COMMON | 015351109 |
| — | ALLERGAN INC | 561,333 | $62.35M | 2.7% | $90.33 | — | COMMON | 018490102 |
| INCY | INCYTE CORPORATION | 1,185,260 | $60.01M | 2.6% | $21.85 | +99.1% | COMMON | 45337C102 |
| — | MYLAN INC | 1,368,707 | $59.4M | 2.6% | $32.67 | — | COMMON | 628530107 |
| IRWD | IRONWOOD PHARMACEUCL | 5,084,999 | $59.04M | 2.5% | $11.94 | -24.8% | COM CL A | 46333X108 |
| TMO | THERMO FISHER SCI | 516,600 | $57.52M | 2.5% | $81.16 | +17.8% | COMMON | 883556102 |
| MRK | MERCK & CO INC | 1,094,683 | $54.79M | 2.4% | $30.12 | +3.9% | COMMON | 58933Y105 |
| — | CELLDEX THERAPEUTICS | 2,227,688 | $53.93M | 2.3% | $28.97 | — | COMMON | 15117B103 |
| — | NPS PHARMACEUTICALS | 1,774,919 | $53.89M | 2.3% | $15.11 | — | COMMON | 62936P103 |
| — | ACTAVIS PLC | 307,150 | $51.6M | 2.2% | $168.00 | — | SHS | G0083B108 |
| — | IMMUNOGEN INC | 3,513,282 | $51.54M | 2.2% | $16.59 | — | COMMON | 45253H101 |
| PRGO | PERRIGO CO | 327,268 | $50.22M | 2.2% | $144.14 | 0.0% | COMMON | G97822103 |
| BMRN | BIOMARIN PHARMAC INC | 713,806 | $50.22M | 2.2% | $62.32 | +9.0% | COMMON | 09061G101 |
| — | ISIS PHARMACEUTICALS | 1,222,401 | $48.7M | 2.1% | $39.01 | — | COMMON | 464330109 |
| — | SYNAGEVA BIOPHARMA | 739,005 | $47.83M | 2.1% | $63.87 | — | COMMON | 87159A103 |
| — | ONCOMED PHARMACEUT | 1,220,006 | $36.02M | 1.6% | $17.18 | — | COMMON | 68234X102 |
| — | KERYX BIOPHARMACEUT | 2,758,950 | $35.73M | 1.5% | $12.95 | — | COMMON | 492515101 |
| — | CLOVIS ONCOLOGY | 472,400 | $28.47M | 1.2% | $63.53 | — | COMMON | 189464100 |
| — | PORTOLA PHARMACEUTIC | 1,001,814 | $25.8M | 1.1% | $24.61 | — | COMMON | 737010108 |
| INSM | INSMED INC | 1,492,121 | $25.37M | 1.1% | $12.78 | +19.8% | COMMON | 457669307 |
| BSX | BOSTON SCIENTIFIC | 2,101,605 | $25.26M | 1.1% | $9.46 | +24.9% | COMMON | 101137107 |
| ISRG | INTUITIVE SURGIC INC | 65,725 | $25.24M | 1.1% | $42.08 | 0.0% | COMMON | 46120E602 |
| ABBV | ABBVIE INC | 472,672 | $24.96M | 1.1% | $30.39 | 0.0% | COMMON | 00287Y109 |
| — | MEDIVATION INC | 388,760 | $24.81M | 1.1% | $49.20 | — | COMMON | 58501N101 |
| — | COVIDIEN PLC | 362,479 | $24.68M | 1.1% | $63.17 | — | SHS | G2554F113 |
| TEVA | TEVA PHARMACEUTICAL | 613,649 | $24.59M | 1.1% | $39.40 | — | ADR | 881624209 |
| — | MALLINCKRODT PLC | 454,364 | $23.75M | 1.0% | $47.71 | — | SHS | G5785G107 |
| ILMN | ILLUMINA INC | 210,689 | $23.3M | 1.0% | $64.01 | +43.1% | COMMON | 452327109 |
| — | AKORN INC | 887,482 | $21.85M | 0.9% | $15.40 | — | COMMON | 009728106 |
| UTHR | UNITED THERAPEUTICS | 182,000 | $20.58M | 0.9% | $90.18 | 0.0% | COMMON | 91307C102 |
| ALGN | ALIGN TECH INC | 321,047 | $18.34M | 0.8% | $34.47 | +56.2% | COMMON | 016255101 |
| — | PHARMACYCLICS INC | 168,425 | $17.82M | 0.8% | $79.47 | — | COMMON | 716933106 |
| RDY | DR REDDYS LABS LTD | 434,190 | $17.82M | 0.8% | $37.82 | — | ADR | 256135203 |
| — | SAGENT PHARMACEUTI | 689,729 | $17.5M | 0.8% | $21.78 | — | COMMON | 786692103 |
| — | SEATTLE GENETICS INC | 422,519 | $16.85M | 0.7% | $31.46 | — | COMMON | 812578102 |
| — | MOMENTA PHARMACEUTIC | 894,696 | $15.82M | 0.7% | $15.19 | — | COMMON | 60877T100 |
| — | HEARTWARE INTL INC | 165,675 | $15.56M | 0.7% | $94.68 | — | COMMON | 422368100 |
| — | TORNIER N V | 573,321 | $10.77M | 0.5% | $17.82 | — | SHS | N87237108 |
| ARAY | ACCURAY INC | 868,386 | $7.555M | 0.3% | $5.05 | +53.6% | COMMON | 004397105 |
| — | NXSTAGE MEDICAL | 753,434 | $7.534M | 0.3% | $14.28 | — | COMMON | 67072V103 |
| DXCM | DEXCOM INC | 160,217 | $5.673M | 0.2% | $4.79 | +65.3% | COMMON | 252131107 |
| HOLX | HOLOGIC INC | 239,485 | $5.352M | 0.2% | $20.89 | +5.5% | COMMON | 436440101 |
| NVO | NOVO-NORDISK AS | 20,126 | $3.718M | 0.2% | $157.61 | — | ADR | 670100205 |
| — | RELYPSA INC | 50,000 | $1.25M | 0.1% | $25.00 | — | COMMON | 759531106 |
| PTCT | PTC THERAPEUTICS I | 57,519 | $976K | 0.0% | $16.22 | +8.3% | COMMON | 69366J200 |
| NVS | NOVARTIS AG | 12,100 | $973K | 0.0% | $72.72 | — | SP ADR | 66987V109 |
| — | KARYOPHARM THERAPE | 35,000 | $802K | 0.0% | $22.91 | — | COMMON | 48576U106 |
| — | TANDEM DIABETES CA | 20,000 | $515K | 0.0% | $25.75 | — | COMMON | 875372104 |
| — | ACCELERON PHARMA | 9,827 | $389K | 0.0% | $39.58 | — | COMMON | 00434H108 |
| — | WUXI PHAR ADS | 6,000 | $230K | 0.0% | $38.33 | — | SP ADR | 929352102 |